STATE OF NEW YORK
ELDERLY PHARMACEUTICAL INSURANCE COVERAGE PROGRAM
EPIC
Annual Data Tables
PROGRAM YEAR
OCTOBER 2005
TO
SEPTEMBER 2006
This page has been
intentionally left blank for
formatting purposes.
Elderly Pharmaceutical Insurance Coverage Program
EPIC Annual Data Tables
October 2005 to September 2006
Table of Contents
Table I: Applications and Enrollment by County ………………………………………….
Table II: Enrollment Changes by County ……………………………………………………
Table III: Utilization by Coverage Type, Marital Status and Income ………………..
Tables IV-A: Claims, Expenditures and Revenue by Program Year; …………………
IV-B: Payment and Utilization by Program Year ……………………….……….
Tables V-A: Distribution of Drug Claims by Volume and Total Prescription Cost; ..
V-B: Distribution of Drugs Purchased by Total Prescription Cost ….………
Table VI: 300 Most Frequently Purchased Drugs ……………………………….………..
Table VII: Ten Most Frequently Purchased Types of Drugs by Therapeutic
Classification …………………………………………………………………………
Table VIII: Twenty Most Frequently Purchased Drugs ……………………………..…..
Table IX: Top Twenty Drugs Based on EPIC Payments ……………………………...….
Table X: Distribution of Claims and Payments by Pharmacy Type …………………...
Table XI: Active Pharmacies, Claims and Payments by County ……………………….
1
3
5
7
7
9
9
11
19
21
23
25
27
This page has been
intentionally left blank for
formatting purposes.
EPIC Program Annual Data Tables 2005-2006:
Table I
County
Table I
*
Applications and Enrollment by County
Applications
Applications
Received
Received
10/05-09/06
10/87-09/06
Enrollment
as of
09/30/06
Albany
935
14,486
5,787
Allegany
272
3,696
1,521
1,242
16,071
6,501
Broome
Cattaraugus
581
8,121
3,504
Cayuga
473
5,557
2,457
1,142
15,144
6,760
Chautauqua
Chemung
481
7,710
2,868
Chenango
375
5,018
2,116
Clinton
371
5,446
2,242
Columbia
395
4,887
2,107
Cortland
323
3,828
1,636
Delaware
329
4,801
2,078
Dutchess
924
12,291
4,965
5,413
72,692
31,117
Essex
Erie
158
2,707
1,099
Franklin
205
3,857
1,534
Fulton
311
5,188
2,168
Genesee
393
5,111
2,451
Greene
255
4,151
1,661
Herkimer
357
6,940
2,798
Jefferson
435
8,068
3,353
Lewis
181
2,508
1,107
Livingston
300
4,132
1,918
Madison
388
4,978
2,267
3,043
35,701
16,019
Monroe
Montgomery
346
6,042
2,562
Nassau
3,722
63,853
25,117
Niagara
1,187
15,682
6,660
Oneida
1,118
19,662
7,874
Onondaga
1,884
26,587
11,189
Ontario
577
7,291
3,282
Orange
944
16,379
6,425
Orleans
256
2,773
1,250
Oswego
740
9,471
4,004
Otsego
369
5,137
2,023
Putnam
250
4,091
1,741
Rensselaer
563
8,360
3,520
Page 1
Table I - continued
County
Applications
Received
10/05-09/06
Applications
Received
10/87-09/06
Enrollment
as of
09/30/06
Rockland
648
12,180
4,529
Saint Lawrence
385
9,492
3,070
Saratoga
766
8,032
4,386
Schenectady
513
3,521
3,238
Schoharie
160
1,608
952
Schuyler
107
1,944
584
Seneca
170
6,883
910
Steuben
430
6,663
2,737
4,469
69,569
27,070
Sullivan
408
5,428
2,087
Tioga
298
3,638
1,425
Tompkins
309
3,861
1,538
Ulster
644
10,714
4,367
Warren/Hamilton
395
5,129
2,252
Washington
342
4,640
2,131
Wayne
550
6,943
3,131
Suffolk
2,259
40,189
14,848
Wyoming
Westchester
279
3,432
1,651
Yates
218
2,242
1,045
44,588
654,525
269,632
Bronx
2,522
65,119
12,219
Kings
4,632
44,704
28,427
New York
3,790
36,852
17,637
Queens
4,937
75,263
32,918
949
14,688
6,107
16,830
236,626
97,308
61,418
891,151
366,940
Upstate
Subtotal
Richmond
NYC Subtotal
Statewide Total
*
Table I represents the applications received and enrollment by county for the program year
(October 2005-September 2006) as well as total applications received since the program began
in October 1987.
Page 2
EPIC Program Annual Data Tables 2005-2006:
Table II
County
Table II
*
Enrollment Changes by County
Enrollment
Enrollment
as of 9/30/05 as of 9/30/06 Total Change Percent Change
Albany
5,593
5,787
194
3.47%
Allegany
1,398
1,521
123
8.80%
Broome
6,036
6,501
465
7.70%
Cattaraugus
3,289
3,504
215
6.54%
Cayuga
2,235
2,457
222
9.93%
Chautauqua
6,189
6,760
571
9.23%
Chemung
2,703
2,868
165
6.10%
Chenango
1,957
2,116
159
8.12%
Clinton
2,150
2,242
92
4.28%
Columbia
1,920
2,107
187
9.74%
Cortland
1,482
1,636
154
10.39%
Delaware
1,970
2,078
108
5.48%
Dutchess
4,748
4,965
217
4.57%
29,018
31,117
2,099
7.23%
Essex
1,076
1,099
23
2.14%
Erie
Franklin
1,482
1,534
52
3.51%
Fulton
2,098
2,168
70
3.34%
Genesee
2,288
2,451
163
7.12%
Greene
1,594
1,661
67
4.20%
Herkimer
2,712
2,798
86
3.17%
Jefferson
3,254
3,353
99
3.04%
Lewis
1,033
1,107
74
7.16%
Livingston
1,826
1,918
92
5.04%
Madison
2,127
2,267
140
6.58%
14,857
16,019
1,162
7.82%
Monroe
Montgomery
2,494
2,562
68
2.73%
Nassau
24,990
25,117
127
0.51%
Niagara
6,222
6,660
438
7.04%
Oneida
Onondaga
Ontario
7,620
7,874
254
3.33%
10,571
11,189
618
5.85%
3,057
3,282
225
7.36%
Orange
6,289
6,425
136
2.16%
Orleans
1,123
1,250
127
11.31%
Oswego
3,745
4,004
259
6.92%
Otsego
1,902
2,023
121
6.36%
Putnam
1,696
1,741
45
2.65%
Rensselaer
3,361
3,520
159
4.73%
Rockland
4,521
4,529
8
0.18%
Page 3
Table II - continued
County
Enrollment
Enrollment
as of 9/30/05 as of 9/30/06 Total Change Percent Change
Saint Lawrence
3,045
3,070
25
0.82%
Saratoga
4,164
4,386
222
5.33%
Schenectady
3,116
3,238
122
3.92%
Schoharie
897
952
55
6.13%
Schuyler
548
584
36
6.57%
Seneca
834
910
76
9.11%
Steuben
Suffolk
Sullivan
2,588
2,737
149
5.76%
26,243
27,070
827
3.15%
1,968
2,087
119
6.05%
Tioga
1,313
1,425
112
8.53%
Tompkins
1,404
1,538
134
9.54%
Ulster
4,234
4,367
133
3.14%
Warren/Hamilton
2,116
2,252
136
6.43%
Washington
2,024
2,131
107
5.29%
Wayne
2,934
3,131
197
6.71%
14,707
14,848
141
0.96%
1,518
1,651
133
8.76%
940
1,045
105
11.17%
257,219
269,632
12,413
4.83%
Bronx
11,970
12,219
249
2.08%
Kings
28,469
28,427
(42)
-0.15%
New York
16,943
17,637
694
4.10%
Queens
32,876
32,918
42
0.13%
6,151
6,107
(44)
-0.72%
96,409
97,308
899
0.93%
353,628
366,940
13,312
3.76%
Westchester
Wyoming
Yates
Upstate Subtotal
Richmond
NYC Subtotal
Statewide Total
*
Table II represents the enrollment for the program year (October 2005-September 2006) as
well as the previous program year and indicates the change in enrollment.
Page 4
EPIC Program Annual Data Tables 2005-2006: Table III
Table III
*
Utilization by Coverage Type, Marital Status and Income
Percent of
EPIC
Participant Participant Third Party
Category
Participants Payments
Copays
Deductibles** Payments***
Demographic
Coverage
Type
Fee Plan
74.7% $648,123,764
$96,335,844
$751,934
$74,863,906
Deductible Plan
25.3% $165,065,712
$24,739,202
$53,419,080
$26,277,997
Marital
Status
Married, Living Apart
$2,131,843
$391,897
$2,060,283
Annual
Income
$15,581,126
Married
32.3% $246,318,033
$35,172,821
$31,159,542
$33,817,056
Single
65.8% $551,290,317
$83,770,382
$22,619,575
$65,264,564
$5,000 or Less
2.0%
$15,697,540
$1,602,369
$8,349
$2,716,715
$5,001 – $10,000
13.6%
$99,582,583
$13,698,985
$71,640
$16,658,038
$10,001 – $15,000
29.9% $249,274,102
$38,433,310
$176,556
$34,484,751
$15,001 – $20,000
21.2% $202,138,060
$30,945,883
$339,691
$15,749,383
$20,001 – $25,000
14.0% $125,739,912
$18,628,848
$11,925,734
$10,326,699
$8,966,646
$14,747,234
$7,808,304
$25,001 – $30,000
Total
1.9%
8.3%
$59,545,336
$30,001 – $35,000
5.2%
$31,229,278
$4,609,956
$12,122,176
$5,716,855
$35,001 – $40,000
2.8%
$14,902,696
$2,143,178
$6,968,590
$3,505,861
$40,001 – $45,000
2.0%
$9,730,493
$1,400,934
$5,125,501
$2,687,191
$45,001 – $50,000
1.0%
$5,349,476
$644,937
$2,685,543
$1,488,106
100.0% $813,189,476 $121,075,046
$54,171,014
$101,141,903
All
*
Table III provides the percent of participants by Coverage Type, Marital Status and Income for the program year
(October 1, 2005 through September 30, 2006) as related to EPIC Payments, Participant Copays, and Participant
Deductibles.
**
The Deductible Plan participants who changed to Fee Plan participants during the program year result in Deductible
totals in the Fee-related rows in this table.
***
Medicare Part D or other insurance payers.
Page 5
This page has been
intentionally left blank for
formatting purposes.
Page 6
EPIC Program Annual Data Tables 2005-2006: Tables IV
-A and IV-B
Table IV-A
*
Claims, Expenditures and Revenue by Program Year
Seventeenth Eighteenth Nineteenth
Description
Category
(2003-2004) (2004-2005) (2005-2006)
Number of Claims Co-payment
Deductible
Total Claims
Expenditures
Total Cost of Drugs
10,184,193
10,410,256
854,094
932,354
1,107,765
10,773,985
11,116,547
11,518,021
$892,398,354
**
less Third Party Payments
less Participant Co-payments
less Deductible Payments
Less Revenue
9,919,891
$994,273,017 $1,089,577,439
$28,001,001
$74,640,427
$101,141,903
$119,881,862
$119,958,485
$121,075,046
$49,573,370
$52,089,489
$54,171,014
Total EPIC Expenditures
$694,942,121
$747,584,616
$813,189,476
Manufacturers' Rebates
$184,095,071
$246,214,041
$295,721,272
$22,117,521
$18,772,759
$21,192,305
$2,178,558
$5,041,342
$10,153,342
$208,391,150
$270,028,142
$327,066,919
$486,550,971
$477,556,474
$486,122,557
plus Participant Fees
plus Claim Recovery
***
Total Revenue
Net State Cost=
(Expenditures-Revenue)
*
Table IV-A represents Claims, Expenditures and Revenue by Program Year up to October 2005September 2006.
**
Estimated Third Party Payments from Medicare Part D coverage and other insurers.
***
Retroactive Third Party Claim recoveries from Medicare and other insurers.
Table IV-B
*
Payment and Utilization by Program Year
Seventeenth Eighteenth Nineteenth
Paid Claims
(2003-2004) (2004-2005) (2005-2006)
Average EPIC Payment per Claim
$64.50
$67.25
$70.60
Average Deductible Payment per Claim
$58.04
$55.87
$48.90
Average Participant Co-payment per Claim
$12.09
$11.77
$11.63
$2.60
$6.71
$8.78
Average Total Cost per Claim
$82.83
$89.44
$94.60
Number of Participants Reaching Deductible
59,981
58,569
62,511
Number of Participants Reaching Copay limit
37,813
30,060
50,900
**
Average Third Party Payment
*
per Claim
Table IV-B represents Payment and Utilization by program year up to October 2005-September 2006.
**
Estimated Third Party Payments from Medicare Part D coverage and other insurers.
Page 7
This page has been
intentionally left blank for
formatting purposes.
Page 8
EPIC Program Annual Data Tables 2005-2006: Tables
V-A and V-B
Table V-A
Distribution of Drug Claims by
*
Volume and Total Prescription Cost
Total
Cumulative
Prescription Percentage Percentage
Cost**
of Claims
of Claims
Up to $5
$5.01 - $10
1.55%
1.55%
12.65%
14.20%
$10.01 - $15
8.93%
23.13%
$15.01 - $20
4.76%
27.89%
$20.01 - $30
8.11%
36.00%
$30.01 - $40
6.00%
42.00%
$40.01 - $50
5.22%
47.22%
$50.01 - $60
5.42%
52.64%
$60.01 - $70
4.32%
56.96%
$70.01 - $80
5.93%
62.89%
$80.01 - $90
3.41%
66.30%
$90.01 - $100
3.50%
69.80%
22.63%
92.43%
$250.01 - $500
6.67%
99.10%
$500.01 - $2500
0.82%
99.92%
Over $2500
0.08%
100.00%
$100.01 - $250
*
Table V-A provides the percent and cumulative percent of adjudicated claims for the program year
(October 1, 2005 through September 30, 2006) as they fall into particular ranges of Total Prescription
Cost.
**
Total Prescription Cost includes participant, EPIC and third-party payments.
Table V-B
Distribution of Drugs
Purchased by Total
*
Prescription Cost
Total
Prescription Percentage
**
Cost
of Claims
Up to $15
23.13%
$15.01 - $35
16.14%
$35.01 - $55
10.67%
$55.01 - $100
19.86%
Over $100
30.20%
Total
100.00%
*
Table V-B provides the percent of adjudicated claims for the program year (October 1, 2005 through
September 30, 2006) as they fall into ranges of Total Prescription Cost.
**
Total Prescription Cost includes participant, EPIC and third-party payments.
Page 9
This page has been
intentionally left blank for
formatting purposes.
Page 10
EPIC Program Annual Data Tables 2005-2006:
Table VI
Table VI
*
300 Most Frequently Purchased Drugs
Rank by
Number
of
Claims
Number
Drug
of
**
Claims
Type
Drug and Strength
EPIC
Payments
Rank by
Payment
1
FUROSEMIDE (40 MG)
Gen
171,779
$733,478
195
2
LIPITOR (10 MG)
SS
166,260
$17,192,756
5
3
PLAVIX (75 MG)
SS
161,754
$28,653,466
1
4
FOSAMAX (70 MG)
SS
147,244
$14,827,200
7
5
NORVASC (5 MG)
SS
136,209
$8,566,206
12
6
HYDROCHLOROTHIAZIDE (25 MG)
Gen
130,927
$430,984
310
7
METOPROLOL TARTRATE (50 MG)
Gen
121,336
$495,058
270
8
LIPITOR (20 MG)
SS
116,196
$17,619,069
4
9
FUROSEMIDE (20 MG)
Gen
113,674
$438,058
303
10
TOPROL XL (50 MG)
SS
112,041
$3,713,908
42
11
PROTONIX (40 MG)
SS
106,727
$16,640,035
6
12
NORVASC (10 MG)
SS
103,534
$8,527,368
13
13
ATENOLOL (50 MG)
Gen
100,342
$572,003
238
14
NEXIUM (40 MG)
SS
97,702
$21,126,918
2
15
METFORMIN HCL (500 MG)
Gen
95,946
$1,644,686
102
16
PREVACID (30 MG)
SS
87,638
$18,284,531
3
17
ACTONEL (35 MG)
SS
84,069
$7,994,458
16
18
FOLIC ACID (1 MG)
Gen
78,198
$560,138
245
19
XALATAN (0.005%)
SS
77,833
$4,083,814
36
20
ATENOLOL (25 MG)
Gen
76,985
$444,913
298
21
AMBIEN (10 MG)
SS
73,201
$5,153,323
26
22
TOPROL XL (100 MG)
SS
71,939
$3,816,241
40
23
ZETIA (10 MG)
SS
71,114
$8,332,796
15
24
ALBUTEROL (90 MCG)
Gen
68,325
$520,937
256
25
FLOMAX (0.4 MG)
SS
64,523
$5,590,561
22
26
HYDROCODONE-ACETAMINOPHEN (5 Gen
MG-500MG)
64,161
$358,418
374
27
TRIAMTERENE-HCTZ (37.5-25 MG)
63,473
$708,050
201
28
TOPROL XL (25 MG)
SS
62,586
$1,975,708
83
29
OMEPRAZOLE (20 MG)
Gen
60,370
$7,942,639
18
30
ADVAIR DISKUS (250-50MCG)
SS
59,285
$7,137,147
19
31
SPIRIVA (18MCG)
SS
57,863
$5,396,369
23
32
ZOCOR (20 MG)
BNMS
57,615
$11,930,543
8
33
LIPITOR (40 MG)
SS
56,931
$8,585,831
11
Gen
34
LISINOPRIL (20 MG)
Gen
53,152
$1,086,165
137
35
LISINOPRIL (10 MG)
Gen
52,792
$918,757
161
36
ISOSORBIDE MONONITRATE (30 MG) Gen
52,420
$1,798,449
92
Page 11
Table VI - continued
Rank by
Number
of
Claims
Number
Drug
of
Type** Claims
Drug and Strength
EPIC
Payments
Rank by
Payment
37
AMOXICILLIN (500 MG)
Gen
51,835
$225,325
519
38
GLYBURIDE (5 MG)
Gen
51,229
$999,534
151
39
ARICEPT (10 MG)
SS
51,005
$8,829,972
10
40
POTASSIUM CHLORIDE (20 MEQ)
Gen
48,685
$902,082
165
41
POTASSIUM CHLORIDE (10 MEQ)
Gen
47,285
$571,625
239
42
COMBIVENT (18-103MCG)
SS
47,179
$2,969,647
51
43
PROPOXYPHENE NAPACETAMINOPHEN (100-650 MG)
Gen
43,404
$439,328
302
44
COSOPT (2%-0.5%)
SS
43,237
$2,988,782
50
45
HYDROCHLOROTHIAZIDE (12.5 MG)
Gen
43,103
$516,804
257
46
SINGULAIR (10 MG)
SS
43,092
$5,223,591
24
47
CELEBREX (200 MG)
SS
42,769
$5,816,228
21
48
ZOCOR (40 MG)
SS
41,598
$8,434,304
14
49
ISOSORBIDE MONONITRATE (60 MG) Gen
39,745
$394,900
333
50
METFORMIN HCL (1000 MG)
Gen
39,681
$886,777
168
51
ZOLOFT (50 MG)
SS
39,557
$4,170,328
35
52
EVISTA (60 MG)
SS
39,338
$5,069,280
27
53
NAMENDA (10 MG)
SS
38,892
$4,482,820
31
54
ALTACE (10 MG)
SS
38,234
$3,325,457
44
55
METOPROLOL TARTRATE (25 MG)
Gen
37,323
$240,298
486
56
COZAAR (50 MG)
SS
37,215
$2,860,366
53
57
LEXAPRO (10 MG)
SS
37,012
$3,116,702
48
58
LANTUS (100/ML)
SS
36,755
$3,300,449
45
59
LEVAQUIN (500 MG)
SS
36,664
$2,382,354
65
60
ACIPHEX (20 MG)
SS
36,330
$7,961,133
17
61
DIOVAN (160 MG)
SS
36,028
$2,821,766
55
62
LISINOPRIL (40 MG)
Gen
35,930
$1,070,639
140
63
WARFARIN SODIUM (5 MG)
Gen
35,872
$597,171
230
64
DIGITEK (125 MCG)
Gen
35,801
$231,580
500
65
ALPRAZOLAM (0.25 MG)
Gen
35,720
$194,723
573
66
DIGOXIN (125 MCG)
Gen
35,557
$260,912
459
67
AVANDIA (4 MG)
SS
35,174
$4,733,521
29
68
DIOVAN (80 MG)
SS
34,830
$2,447,234
61
69
AMBIEN (5 MG)
SS
34,532
$2,621,120
59
70
AZITHROMYCIN (250 MG)
Gen
34,466
$797,504
179
71
DETROL LA (4 MG)
SS
33,519
$4,299,044
33
72
RANITIDINE HCL (150 MG)
Gen
33,468
$288,268
428
73
KLOR-CON 10 (10 MEQ)
Gen
32,898
$420,105
316
74
SPIRONOLACTONE (25 MG)
Gen
32,702
$428,681
313
75
CIPROFLOXACIN HCL (500 MG)
Gen
32,226
$238,275
489
76
METOPROLOL TARTRATE (100 MG)
Gen
32,154
$173,498
612
77
ALPHAGAN P (0.15 %)
SS
32,010
$2,223,761
71
78
PREDNISONE (5 MG)
Gen
31,933
$73,932
979
Page 12
Table VI - continued
Rank by
Number
of
Claims
Number
Drug
of
Type** Claims
Drug and Strength
EPIC
Payments
Rank by
Payment
79
LEVOTHYROXINE SODIUM (50 MCG)
Gen
30,972
$320,219
403
80
ATENOLOL (100 MG)
Gen
30,656
$266,640
451
81
ENALAPRIL MALEATE (10 MG)
Gen
30,227
$722,498
198
82
ENALAPRIL MALEATE (20 MG)
Gen
29,877
$976,935
154
83
GABAPENTIN (300 MG)
Gen
29,549
$2,175,102
76
84
COREG (6.25 MG)
SS
28,598
$2,726,198
58
85
LISINOPRIL (5 MG)
Gen
28,477
$464,540
287
86
METFORMIN HCL ER (500 MG)
Gen
28,035
$831,194
176
87
KLOR-CON M20 (20 MEQ)
Gen
27,842
$489,418
274
88
ACETAMINOPHEN-CODEINE (300MG- Gen
30MG)
27,675
$273,672
443
89
ALTACE (5 MG)
SS
27,605
$1,746,724
96
90
TIMOLOL MALEATE (0.5 %)
Gen
27,177
$440,534
301
91
VERAPAMIL HCL (240 MG)
Gen
27,059
$487,455
275
92
PRAVACHOL (40 MG)
SS
26,991
$6,099,808
20
93
CEPHALEXIN (500 MG)
Gen
26,376
$210,986
542
94
LUMIGAN (0.03%)
SS
26,062
$2,369,778
67
95
ALLOPURINOL (100 MG)
Gen
25,724
$131,232
730
96
MIACALCIN (200/DOSE)
SS
25,678
$1,701,768
97
97
LIDODERM (5%(700MG))
SS
25,495
$4,578,099
30
98
LEVOTHYROXINE SODIUM (75 MCG)
Gen
25,492
$296,807
419
99
PREDNISONE (10 MG)
Gen
25,252
$84,669
911
100
ZYRTEC (10 MG)
SS
25,224
$1,972,564
84
101
ENALAPRIL MALEATE (5 MG)
Gen
24,626
$456,945
292
102
LEVOTHYROXINE SODIUM (100 MCG) Gen
24,571
$294,865
422
103
QUINAPRIL HCL (40 MG)
Gen
24,192
$966,141
157
104
WARFARIN SODIUM (2 MG)
Gen
24,165
$455,503
293
105
GLYCOLAX (17G/DOSE)
BNMS
24,133
$395,854
332
106
TRICOR (145MG)
SS
24,068
$3,632,126
43
107
TRAMADOL HCL (50 MG)
Gen
23,978
$417,620
317
108
COREG (12.5 MG)
SS
23,970
$2,307,006
70
109
DIOVAN HCT (160-12.5MG)
SS
23,834
$2,140,662
78
110
PAROXETINE HCL (20 MG)
Gen
23,810
$1,922,577
85
111
AVAPRO (150 MG)
SS
23,713
$1,579,155
107
112
SYNTHROID (50 MCG)
BNMS
23,631
$364,368
364
113
CARBIDOPA-LEVODOPA (25MG100MG)
Gen
23,620
$770,112
185
114
ZOLOFT (100 MG)
SS
23,363
$2,435,467
62
115
NORVASC (2.5 MG)
SS
23,108
$1,452,648
114
116
SYNTHROID (75 MCG)
BNMS
22,904
$387,748
338
117
COREG (25 MG)
SS
22,676
$2,191,219
74
118
WARFARIN SODIUM (1 MG)
Gen
22,596
$462,401
290
119
SYNTHROID (100 MCG)
BNMS
22,298
$404,646
323
Page 13
Table VI - continued
Rank by
Number
of
Claims
Number
Drug
of
Type** Claims
Drug and Strength
EPIC
Payments
Rank by
Payment
120
COZAAR (100 MG)
SS
22,245
$2,137,207
79
121
ADVAIR DISKUS (500-50MCG)
SS
22,214
$3,852,242
39
122
ADVAIR DISKUS (100-50MCG)
SS
22,181
$2,074,165
81
123
HYDROCODONE-ACETAMINOPHEN
(7.5-500MG)
Gen
22,043
$233,310
497
124
PROSCAR (5 MG)
SS
21,945
$2,746,486
57
125
ALLOPURINOL (300 MG)
Gen
21,921
$131,716
726
125
LOVASTATIN (20 MG)
Gen
21,921
$710,426
200
127
LOVASTATIN (40 MG)
Gen
21,894
$1,496,499
112
128
ARICEPT (5 MG)
SS
21,466
$3,783,791
41
129
LOTREL (5MG-20MG)
SS
20,837
$2,434,747
63
130
GEMFIBROZIL (600 MG)
Gen
20,541
$346,319
386
131
TRAMADOL HCL-ACETAMINOPHEN
(37.5-325MG)
Gen
20,426
$1,024,029
146
132
GLIPIZIDE ER (10 MG)
Gen
20,332
$570,859
240
133
ALPRAZOLAM (0.5 MG)
Gen
20,322
$133,441
720
134
AVAPRO (300 MG)
SS
20,238
$1,575,528
108
135
FUROSEMIDE (80 MG)
Gen
20,149
$136,737
702
136
NITROQUICK (0.4 MG)
Gen
20,073
$112,448
791
137
PROPOXYPHENE NAPSYLATE-APAP
(100-650 MG)
Gen
19,995
$207,020
548
138
GABAPENTIN (100 MG)
Gen
19,959
$599,074
228
139
COREG (3.125MG)
SS
19,914
$1,854,351
90
140
ACTOS (30 MG)
SS
19,856
$4,794,211
28
141
MECLIZINE HCL (25 MG)
Gen
19,621
$73,411
983
142
MOBIC (7.5 MG)
SS
19,578
$2,611,682
60
143
QUINAPRIL HCL (20 MG)
Gen
19,473
$762,880
187
144
LORAZEPAM (0.5 MG)
Gen
19,446
$413,725
319
145
VYTORIN (10MG-40MG)
SS
19,409
$2,200,870
73
146
VYTORIN (10MG-20MG)
SS
19,292
$2,191,145
75
147
HUMULIN N (100/ML)
BNMS
19,145
$896,917
166
148
ALTACE (2.5 MG)
SS
19,140
$1,059,521
142
149
SULFAMETHOXAZOLETRIMETHOPRIM (800-160MG)
Gen
19,032
$65,029
1050
150
LEVOTHYROXINE SODIUM (25 MCG)
Gen
18,902
$169,195
625
151
WARFARIN SODIUM (2.5 MG)
Gen
18,873
$347,273
385
152
CRESTOR (10 MG)
SS
18,677
$2,209,636
72
153
HYZAAR (100MG-25MG)
SS
18,653
$1,856,995
89
154
PRAVACHOL (20 MG)
SS
18,502
$2,854,880
54
155
GLYBURIDE-METFORMIN HCL (5 MG- Gen
500MG)
18,309
$981,367
153
156
BONIVA (150 MG)
SS
17,760
$1,647,278
101
157
GLIPIZIDE ER (5 MG)
Gen
17,746
$260,414
463
158
AMIODARONE HCL (200 MG)
Gen
17,704
$1,021,338
148
Page 14
Table VI - continued
Rank by
Number
of
Claims
Number
Drug
of
Type** Claims
Drug and Strength
EPIC
Payments
Rank by
Payment
159
FAMOTIDINE (20 MG)
Gen
17,493
$141,250
692
160
MECLIZINE HCL (12.5 MG)
Gen
17,472
$80,232
937
161
NITROGLYCERIN PATCH (0.4MG/HR) Gen
17,127
$480,307
278
162
SEROQUEL (25 MG)
SS
17,007
$1,608,732
104
163
GLIPIZIDE (5 MG)
Gen
16,898
$87,331
901
164
LIPITOR (80 MG)
SS
16,843
$2,351,238
68
165
COUMADIN (5 MG)
BNMS
16,728
$606,874
226
166
ACTOS (15 MG)
SS
16,725
$2,378,665
66
167
AVANDIA (8 MG)
SS
16,525
$3,919,339
38
168
DIAZEPAM (5 MG)
Gen
16,402
$95,297
851
169
DIGITEK (250 MCG)
Gen
16,322
$106,270
808
170
ALBUTEROL SULFATE (2.5 MG/3ML)
Gen
16,268
$294,388
423
171
HYDROCODONE-ACETAMINOPHEN
(7.5-750MG)
Gen
16,255
$135,249
705
172
ARIMIDEX (1 MG)
SS
16,222
$5,204,218
25
173
CLONIDINE HCL (0.1 MG)
Gen
16,050
$112,096
792
174
CLOTRIMAZOLE-BETAMETHASONE (1 Gen
-0.05%)
15,997
$501,062
265
175
FEXOFENADINE HCL (180 MG)
15,979
$1,195,018
129
176
ACTOS (45 MG)
SS
15,870
$4,292,764
34
177
METHOTREXATE (2.5 MG)
Gen
15,758
$724,968
197
178
ZOCOR (10 MG)
SS
15,742
$1,798,015
93
179
NASONEX (50 MCG)
SS
15,677
$741,467
193
180
DIGOXIN (250 MCG)
Gen
15,560
$112,703
790
181
GLYBURIDE (2.5 MG)
Gen
15,533
$164,887
638
182
INSULIN SYRINGE (30GX1/2")
Syrn
15,413
$237,356
491
183
HYDROCHLOROTHIAZIDE (50 MG)
Gen
15,303
$79,432
944
184
COLCHICINE (0.6 MG)
Gen
15,300
$120,478
771
Gen
185
TRAVATAN (0.004%)
SS
15,281
$1,112,636
134
186
GLIMEPIRIDE (4 MG)
Gen
15,174
$382,174
345
187
LOTREL (10MG-20MG)
SS
14,928
$1,757,846
95
188
FLONASE (50 MCG)
BNMS
14,889
$775,383
182
189
CIPROFLOXACIN HCL (250 MG)
Gen
14,881
$90,655
876
190
TOPROL XL (200 MG)
SS
14,741
$1,241,568
126
191
WARFARIN SODIUM (3 MG)
Gen
14,671
$227,984
512
192
NITROGLYCERIN PATCH (0.2MG/HR) Gen
14,604
$359,231
371
193
CITALOPRAM HBR (20 MG)
14,562
$211,698
538
194
HYZAAR (50-12.5MG)
SS
14,475
$1,072,549
139
195
LISINOPRIL-HCTZ (20-12.5 MG)
Gen
14,423
$354,504
379
196
LESCOL XL (80 MG)
SS
14,422
$1,693,921
98
Gen
197
NAPROXEN (500 MG)
Gen
14,314
$155,829
653
198
CLONAZEPAM (0.5 MG)
Gen
14,304
$196,952
568
199
DILTIAZEM 24HR ER (240 MG)
Gen
14,255
$859,515
174
Page 15
Table VI - continued
Rank by
Number
of
Claims
Number
Drug
of
Type** Claims
Drug and Strength
EPIC
Payments
Rank by
Payment
200
LEXAPRO (20 MG)
SS
13,648
$1,153,592
131
201
DIOVAN (320MG)
SS
13,565
$1,309,980
120
202
LORAZEPAM (1 MG)
Gen
13,532
$401,868
326
203
GLIPIZIDE (10 MG)
Gen
13,481
$96,527
849
204
LEVAQUIN (250 MG)
SS
13,472
$654,975
212
205
PREDNISONE (20 MG)
Gen
13,448
$38,759
1301
206
OXYCODONE-ACETAMINOPHEN (5MG Gen
-325MG)
13,410
$138,808
698
207
PAROXETINE HCL (10 MG)
Gen
13,261
$1,031,944
144
208
METHYLPREDNISOLONE (4 MG)
Gen
13,252
$92,310
864
209
AMOX TR-POTASSIUM CLAVULANATE Gen
(875-125 MG)
13,150
$615,127
225
210
TRIAMCINOLONE ACETONIDE (0.1%) Gen
13,137
$82,819
920
211
WARFARIN SODIUM (4 MG)
Gen
12,977
$195,895
571
212
AMBIEN CR (12.5 MG)
SS
12,949
$880,479
171
213
METFORMIN HCL (850 MG)
Gen
12,880
$242,466
485
214
FLUOXETINE HCL (20 MG)
Gen
12,837
$156,637
651
215
CLARINEX (5 MG)
SS
12,601
$1,272,646
123
216
AGGRENOX (25-200MG)
SS
12,570
$1,407,530
116
217
TRAZODONE HCL (50 MG)
Gen
12,520
$54,065
1136
218
HUMULIN 70-30 (70-30/ML)
BNMS
12,516
$688,375
206
219
LOTREL (5-10MG)
SS
12,492
$1,261,284
125
220
DUONEB (0.5-2.5/3)
SS
12,392
$1,829,689
91
221
AMITRIPTYLINE HCL (25 MG)
Gen
12,353
$55,077
1124
222
NIASPAN (500 MG)
SS
12,346
$1,038,666
143
223
QUINAPRIL HCL (10 MG)
Gen
12,240
$463,796
288
224
LEVOTHYROXINE SODIUM (125 MCG) Gen
12,187
$150,492
669
225
PENTOXIFYLLINE (400 MG)
Gen
12,130
$230,952
504
226
SYNTHROID (25 MCG)
BNMS
12,032
$168,496
627
227
KLOR-CON M10 (10 MEQ)
Gen
11,934
$136,974
700
228
LANOXIN (125 MCG)
BNMS
11,904
$114,387
783
229
DIOVAN HCT (80-12.5MG)
SS
230
NYSTATIN-TRIAMCINOLONE (100000 Gen
-0.1)
231
CLOPIDOGREL BISULFATE (75 MG)
232
DILTIAZEM 24HR ER (180 MG)
233
ZYMAR (0.3 %)
234
234
236
11,803
$929,926
159
11,780
$57,231
1106
Gen
11,756
$1,530,064
109
Gen
11,689
$505,096
262
SS
11,622
$361,180
368
DIOVAN HCT (160-25MG)
SS
11,438
$1,113,913
133
VIGAMOX (0.5 %)
SS
11,438
$363,587
365
RESTASIS (0.05%)
SS
11,425
$1,273,380
122
237
CYCLOBENZAPRINE HCL (10 MG)
Gen
11,387
$111,156
798
238
PRAVASTATIN SODIUM (40 MG)
Gen
11,361
$1,877,631
88
239
MIRTAZAPINE (15 MG)
Gen
11,338
$499,879
267
Page 16
Table VI - continued
Rank by
Number
of
Claims
Number
Drug
of
Type** Claims
Drug and Strength
EPIC
Payments
Rank by
Payment
240
TORSEMIDE (20 MG)
Gen
11,325
$354,317
380
241
DOXAZOSIN MESYLATE (4 MG)
Gen
11,182
$231,345
501
242
FOSINOPRIL SODIUM (40 MG)
Gen
11,110
$353,755
381
243
PREDNISOLONE ACETATE (1 %)
Gen
11,107
$133,637
716
244
EFFEXOR XR (75 MG)
SS
11,079
$1,640,828
103
245
SYNTHROID (88MCG)
BNMS
11,021
$192,373
578
246
METOCLOPRAMIDE HCL (10 MG)
Gen
10,996
$78,529
950
247
AVODART (0.5 MG)
SS
10,949
$1,209,135
128
248
FLOVENT HFA (110MCG)
SS
10,946
$762,639
188
249
CILOSTAZOL (100 MG)
Gen
10,912
$564,539
243
250
SYNTHROID (125 MCG)
BNMS
10,868
$226,401
517
251
QUININE SULFATE (260 MG)
Gen
10,794
$208,864
544
252
CLONIDINE HCL (0.2 MG)
Gen
10,751
$89,510
885
253
VERAPAMIL HCL (180 MG)
Gen
10,718
$222,222
521
254
INSULIN SYRINGE (31GX5/16")
Syrn
10,712
$167,537
630
255
PHENYTOIN SODIUM EXTENDED (100 Gen
MG)
10,660
$167,337
631
256
DOXYCYCLINE HYCLATE (100 MG)
Gen
10,659
$40,837
1271
257
ASACOL (400 MG)
SS
10,610
$1,606,392
105
258
LISINOPRIL-HCTZ (20-25MG)
Gen
10,566
$247,551
477
259
COUMADIN (2 MG)
BNMS
10,563
$403,599
325
260
FOSAMAX PLUS D (70 MG-2800)
SS
10,554
$1,021,898
147
261
LEVOTHYROXINE SODIUM (88MCG)
Gen
10,553
$129,057
733
262
OXYBUTYNIN CHLORIDE (5 MG)
Gen
10,498
$67,534
1028
263
FOSINOPRIL SODIUM (20 MG)
Gen
10,492
$373,762
352
264
AVALIDE (300-12.5MG)
SS
10,430
$911,090
163
265
TRUSOPT (2 %)
SS
10,359
$370,034
356
266
FLUTICASONE PROPIONATE (50
MCG)
Gen
10,333
$356,919
377
267
ZOLOFT (25 MG)
SS
10,265
$1,009,741
150
268
PREDNISONE (1 MG)
BNMS
10,222
$122,264
761
269
SIMVASTATIN (20 MG)
Gen
10,159
$1,526,548
110
270
COZAAR (25 MG)
SS
10,005
$690,891
205
271
FLUOCINONIDE (0.05%)
Gen
9,982
$101,851
825
272
CARTIA XT (240 MG)
Gen
9,952
$648,405
215
273
COUMADIN (2.5 MG)
BNMS
9,929
$366,319
362
274
STARLIX (120 MG)
SS
9,884
$815,660
177
275
MOBIC (15 MG)
SS
9,868
$1,883,986
87
276
DILTIAZEM 24HR ER (120 MG)
Gen
9,804
$331,680
397
277
FOSAMAX (35 MG)
SS
9,752
$908,908
164
278
GLIMEPIRIDE (2 MG)
Gen
9,741
$124,949
751
279
AMITRIPTYLINE HCL (10 MG)
Gen
9,694
$42,415
1251
280
IBUPROFEN (600 MG)
Gen
9,692
$43,351
1246
Page 17
Table VI - continued
Rank by
Number
of
Claims
Number
Drug
of
Type** Claims
Drug and Strength
EPIC
Payments
Rank by
Payment
281
ENALAPRIL MALEATE (2.5 MG)
Gen
9,658
$145,868
683
282
DILANTIN (100 MG)
BNMS
9,657
$198,087
565
283
LABETALOL HCL (200 MG)
Gen
9,454
$187,905
588
284
PATANOL (0.1%)
SS
9,258
$508,972
261
285
GLYBURIDE-METFORMIN HCL (2.5500MG)
Gen
9,200
$442,268
300
286
AVELOX (400 MG)
SS
9,199
$545,789
249
286
DITROPAN XL (10 MG)
SS
9,199
$1,304,773
121
288
TERAZOSIN HCL (5 MG)
Gen
9,152
$227,153
515
289
AVALIDE (150-12.5MG)
SS
9,093
$774,124
183
290
FOSINOPRIL SODIUM (10 MG)
Gen
9,026
$296,479
420
291
HUMALOG (100/ML)
SS
9,000
$972,888
155
292
QUININE SULFATE (325 MG)
Gen
8,947
$192,012
579
293
CLINDAMYCIN HCL (150 MG)
Gen
8,911
$115,145
781
294
PREVACID (15 MG)
SS
8,886
$1,997,330
82
295
COUMADIN (1 MG)
BNMS
8,796
$358,581
373
296
HYDROXYCHLOROQUINE SULFATE
(200 MG)
Gen
8,680
$295,357
421
297
HYDROXYZINE HCL (25 MG)
Gen
8,672
$202,223
558
298
LEVOXYL (50 MCG)
Gen
8,660
$100,847
830
299
CLOBETASOL PROPIONATE (0.05%)
Gen
8,526
$226,863
516
300
NIFEDIPINE ER (90 MG)
Gen
8,473
$649,024
214
*
Table VI represents the top 300 drugs ranked by number of adjudicated claims for the program
year (October 2005-September 2006) as well as the rank by EPIC payment.
**
Drug Type values are BNMS='Brand Name Multi-Source', Gen='Generic', SS='Sole Source', and
Syrn='Insulin Syringe'. The indicated drug type is the type identified at the close of the program
year.
Page 18
EPIC Program Annual Data Tables 2005-2006:
Table VII
Table VII
Ten Most Frequently Purchased Types of Drugs
*
by Therapeutic Classification
Number Percent
EPIC
Number of
Therapeutic Class**
of Claims of Claims Payments Participants
BETA-ADRENERGIC BLOCKING AGENT
920,498
7.99% $27,873,095
169,592
HMG-COA REDUCTASE INHIBITORS
694,797
6.03% $97,333,548
159,412
ANGIOTENSIN-CONVERTING ENZYME
572,103
4.97% $19,923,456
112,460
PROTON-PUMP INHIBITORS
415,867
3.61% $78,230,749
100,617
DIHYDROPYRIDINES
393,136
3.41% $29,525,356
81,323
ANTIDEPRESSANTS
386,759
3.36% $27,471,336
74,306
ANGIOTENSIN II RECEPTOR ANTAGO
369,125
3.20% $29,651,508
78,518
OPIATE AGONISTS
354,260
3.08% $13,914,074
93,487
LOOP DIURETICS
338,409
2.94%
$2,152,898
76,808
THYROID AGENTS
330,190
2.87%
$4,580,147
64,287
Total
***
4,775,144
41.46% $330,656,167
*
Table VII provides the percent of adjudicated claims for the program year (October 1, 2005
through September 30, 2006) as they fall into particular categories of Therapeutic Class.
**
American Hospital Formulary Service® (AHFS) Pharmacologic-Therapeutic Classification.
***
This report contains the top ten drug classes; additional drug classes comprise the remainder
of claims up to 100.00%.
Page 19
This page has been
intentionally left blank for
formatting purposes.
Page 20
EPIC Program Annual Data Tables 2005-2006: Table
VIII
Rank by Number
of Claims
Table VIII
*
Twenty Most Frequently Purchased Drugs
Drug Number
EPIC
Rank by
**
Drug and Strength
Type of Claims Payments Payment
1
FUROSEMIDE (40 MG)
Gen
171,779
$733,478
195
2
LIPITOR (10 MG)
SS
166,260 $17,192,756
5
3
PLAVIX (75 MG)
SS
161,754 $28,653,466
1
4
FOSAMAX (70 MG)
SS
147,244 $14,827,200
7
5
NORVASC (5 MG)
SS
136,209
$8,566,206
12
6
HYDROCHLOROTHIAZIDE (25 MG) Gen
130,927
$430,984
310
7
METOPROLOL TARTRATE (50 MG) Gen
121,336
$495,058
270
8
LIPITOR (20 MG)
SS
116,196 $17,619,069
4
9
FUROSEMIDE (20 MG)
Gen
113,674
$438,058
303
10
TOPROL XL (50 MG)
SS
112,041
$3,713,908
42
11
PROTONIX (40 MG)
SS
106,727 $16,640,035
6
12
NORVASC (10 MG)
SS
103,534
$8,527,368
13
13
ATENOLOL (50 MG)
Gen
100,342
$572,003
238
14
NEXIUM (40 MG)
SS
97,702 $21,126,918
2
15
METFORMIN HCL (500 MG)
Gen
95,946
$1,644,686
102
16
PREVACID (30 MG)
SS
87,638 $18,284,531
3
17
ACTONEL (35 MG)
SS
84,069
18
FOLIC ACID (1 MG)
Gen
19
XALATAN (0.005%)
SS
20
ATENOLOL (25 MG)
Gen
Top 20 Totals
$7,994,458
16
78,198
$560,138
245
77,833
$4,083,814
36
76,985
$444,913
298
2,286,394 $172,549,047
Percent of Top 20 Drugs to Total Paid Claims
*
19.85% 21.22%
Table VIII lists the top 20 drugs ranked by number of adjudicated claims for the program year (October
1, 2005-September 30, 2006) as well as the percentage of the totals they represent for the year.
**
Drug Type values are Gen='Generic' and SS='Sole Source'.
Page 21
This page has been
intentionally left blank for
formatting purposes.
Page 22
EPIC Program Annual Data Tables 2005-2006: Table IX
Table IX
Top Twenty Drugs Based on EPIC Payments
Number
Rank by
Drug
of
Number
**
Drug and Strength
Type
Claims EPIC Payments of Claims
Rank by
Payment
1
PLAVIX (75 MG)
SS
161,754
$28,653,466
3
2
NEXIUM (40 MG)
SS
97,702
$21,126,918
14
3
PREVACID (30 MG)
SS
87,638
$18,284,531
16
4
LIPITOR (20 MG)
SS
116,196
$17,619,069
8
5
LIPITOR (10 MG)
SS
166,260
$17,192,756
2
6
PROTONIX (40 MG)
SS
106,727
$16,640,035
11
7
FOSAMAX (70 MG)
SS
147,244
$14,827,200
4
8
ZOCOR (20 MG)
SS
57,615
$11,930,543
32
9
PROCRIT (40000/ML)
BNMS
5,147
$9,754,207
427
10
ARICEPT (10 MG)
SS
51,005
$8,829,972
39
11
LIPITOR (40 MG)
SS
56,931
$8,585,831
33
12
NORVASC (5 MG)
SS
136,209
$8,566,206
5
13
NORVASC (10 MG)
SS
103,534
$8,527,368
12
14
ZOCOR (40 MG)
SS
41,598
$8,434,304
48
15
ZETIA (10 MG)
SS
71,114
$8,332,796
23
16
ACTONEL (35 MG)
SS
84,069
$7,994,458
17
17
ACIPHEX (20 MG)
SS
36,330
$7,961,133
60
18
OMEPRAZOLE (20 MG)
Gen
60,370
$7,942,639
29
19
ADVAIR DISKUS (250-50MCG)
SS
59,285
$7,137,147
30
20
PRAVACHOL (40 MG)
SS
26,991
$6,099,808
92
1,673,719 $244,440,387
Top 20 Totals
Percent of Top 20 Drugs to Total EPIC Payments
14.53% 30.06%
*
Table IX lists the top 20 drugs ranked by EPIC Payments and number of adjudicated claims for the
program year (October 1, 2005-September 30, 2006) as well as the percentage of the totals they
represent for the year.
**
Drug Type values are BNMS='Brand Name Multi-Source', Gen='Generic' and SS='Sole Source'.
Page 23
This page has been
intentionally left blank for
formatting purposes.
Page 24
EPIC Program Annual Data Tables 2005-2006: Table X
Table X
*
Distribution of Claims and Payments by Pharmacy Type
Number Number of
**
Type of Pharmacy
Active
Claims Payments to Pharmacies
Chain
Clinical
Independent
2,242
7,484,461
$506,690,524
80
240,554
$10,754,862
2,036
3,789,885
$295,482,329
Mail Order
2
312
$38,556
Other
6
2,809
$223,205
4,366
11,518,021
$813,189,476
Total
*
Table X contains the number of active pharmacies, the number of claims and the sum of the payments
to the pharmacies for each type of pharmacy. Comparison of this table from this program year (October 1,
2005-September 30, 2006) to the previous shows an increase in the total number of pharmacies.
**
Types of Pharmacies include: Chain='Chain'; Clinical='Alternate Dispensing' and 'Government/Federal';
Independent='Independent' and 'Franchise'; Mail Order='Mail Order.
Page 25
This page has been
intentionally left blank for
formatting purposes.
Page 26
EPIC Program Annual Data Tables 2005-2006: Table XI
Table XI
*
Active Pharmacies, Claims and Payments by County
Number of
Active
Number of Payments to
Enrollment
County
Pharmacies Paid Claims Pharmacies as of 09/30/2006
Albany
70
178,194
$13,508,098
5,787
Allegany
12
43,391
$2,832,587
1,521
Broome
43
196,455
$14,077,514
6,501
Cattaraugus
22
109,967
$8,190,226
3,504
Cayuga
13
71,367
$4,455,334
2,457
Chautauqua
36
213,446
$14,114,326
6,760
Chemung
20
98,915
$6,824,178
2,868
Chenango
12
56,151
$3,817,882
2,116
Clinton
19
69,556
$5,256,314
2,242
Columbia
10
57,822
$4,082,929
2,107
Cortland
13
57,232
$3,682,467
1,636
Delaware
14
64,745
$4,638,898
2,078
Dutchess
65
158,196
$10,955,214
4,965
214
1,110,570
$63,527,170
31,117
Essex
12
27,835
$2,007,767
1,099
Franklin
10
47,976
$3,642,511
1,534
Fulton
14
69,171
$5,112,468
2,168
Genesee
12
69,207
$4,834,646
2,451
Erie
Greene
9
46,805
$3,562,063
1,661
Herkimer
14
77,853
$5,641,196
2,798
Jefferson
26
115,825
$7,712,485
3,353
5
28,828
$1,785,465
1,107
Livingston
Lewis
11
58,501
$3,906,662
1,918
Madison
16
66,208
$4,826,536
2,267
145
561,588
$32,220,052
16,019
14
70,444
$4,768,080
2,562
Nassau
303
905,536
$72,452,451
25,117
Niagara
45
206,498
$12,983,418
6,660
Oneida
61
277,759
$19,872,847
7,874
101
391,538
$24,914,706
11,189
Ontario
25
112,672
$6,661,500
3,282
Orange
72
220,434
$17,294,562
6,425
Orleans
9
34,272
$1,992,224
1,250
Oswego
30
112,438
$7,932,869
4,004
Otsego
14
65,351
$3,899,901
2,023
Putnam
20
46,794
$4,870,834
1,741
Rensselaer
30
112,017
$8,149,579
3,520
Rockland
54
148,084
$11,925,530
4,529
Monroe
Montgomery
Onondaga
Page 27
Table XI - continued
County
Number of
Active
Number of Payments to
Enrollment
Pharmacies Paid Claims Pharmacies as of 09/30/2006
Saint Lawrence
19
103,561
$7,196,139
3,070
Saratoga
36
169,403
$11,396,875
4,386
Schenectady
42
107,523
$7,690,588
3,238
Schoharie
5
27,901
$1,888,891
952
Schuyler
4
19,647
$1,328,863
584
Seneca
6
28,897
$1,809,824
910
Steuben
Suffolk
Sullivan
Tioga
19
97,144
$6,894,149
2,737
298
781,099
$64,300,247
27,070
15
48,349
$3,880,789
2,087
7
27,191
$1,729,775
1,425
Tompkins
21
42,999
$2,731,915
1,538
Ulster
30
120,911
$9,616,388
4,367
Warren/Hamilton
18
79,724
$5,649,844
2,252
Washington
13
71,002
$5,092,814
2,131
Wayne
19
86,393
$5,817,610
3,131
195
484,428
$34,774,213
14,848
Wyoming
7
44,308
$3,221,848
1,651
Yates
5
29,681
$2,255,781
1,045
2,374
8,729,802
$610,210,042
269,632
Bronx
292
333,626
$24,247,934
12,219
Kings
621
797,315
$59,185,692
28,427
New York
522
548,581
$40,898,834
17,637
Queens
467
897,579
$65,292,673
32,918
Westchester
Upstate Subtotal
Richmond
NYC Subtotal
Out-of-State**
EPIC Total
83
195,693
$12,324,538
6,107
1,985
2,772,794
$201,949,671
97,308
7
15,425
$1,029,763
0
4,366 11,518,021 $813,189,476
366,940
*
Table XI provides distribution of adjudicated claims for the counties within which the pharmacies are
located for the program year (October 1, 2005 through September 30, 2006).
**
'Out-of-State', per legislation, includes limited pharmacies bordering underserved areas of New York
State.
Page 28
This page has been
intentionally left blank for
formatting purposes.
State of New York
David A. Paterson, Governor
Department of Health
Richard F. Daines, M.D, Commissioner